Countdown to approval: Mesoblast readies for Ryoncil’s FDA milestone
Mesoblast (ASX:MSB; Nasdaq:MESO) has reported significant milestones in its Q1 FY2025 results, including an anticipated FDA ...
Why India needs to rethink its love for pigeons
The practice of feeding the birds has led to unnatural spikes in their population. Their close proximity to humans poses ...